Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology

European Journal of Endocrinology

Volumn 165, Issue 3, 2011, Pages 447-453

  Fadda, Guido ^a   Rossi, Esther Diana ^a   Raffaelli, Marco ^a   Pontecorvi, Alfredo ^a   Sioletic, Stefano ^a   Morassi, Francesca ^a   Lombardi, Celestino Pio ^a   Zannoni, Gian Franco ^a   Rindi, Guido ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 3; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HBME1; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; HBME 1 ANTIGEN; HBME-1 ANTIGEN; TUMOR MARKER; MONOCLONAL ANTIBODY HBME 1;

ARTICLE; ASPIRATION BIOPSY; ASPIRATION CYTOLOGY; BENIGN TUMOR; CANCER RISK; CONTROLLED STUDY; DIAGNOSTIC VALUE; FOLLICULAR THYROID NEOPLASM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LIQUID BASED FINE NEEDLE CYTOLOGY; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID SURGERY; THYROID TUMOR; TUMOR CLASSIFICATION; ADOLESCENT; ADULT; AGED; CLASSIFICATION; CYTODIAGNOSIS; FEMALE; IMMUNOLOGY; MALE; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; RISK ASSESSMENT; THYROID NODULE; CANCER CLASSIFICATION; CANCER CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; FOLLOW UP; HIGH RISK POPULATION; SENSITIVITY AND SPECIFICITY; THYROID CANCER;

ADOLESCENT; ADULT; AGED; BIOPSY, FINE-NEEDLE; CYTODIAGNOSIS; FEMALE; GALECTIN 3; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RISK ASSESSMENT; THYROID NEOPLASMS; THYROID NODULE; TUMOR MARKERS, BIOLOGICAL;

EID: 80051702478     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0181     Document Type: Article

References (40)

1. Gharib H & Goellner JR. Fine-needle aspiration biopsy of the thyroid. Annals of Internal Medicine 1993 118 282-289.
2. Galera-Davidson H & Gonzalez-Campora R. Thyroid. In Comprehensive Cytopathology, ch 23, 3rd edn, pp 633-670. Eds M Bibbo & D Wilbur. Philadelphia: Saunders Elsevier, 2008.
3. Danese D, Sciacchitano S, Farsetti A, Andreoli M & Pontecorvi A. Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. Thyroid 1998 8 15-21. (doi:10.1089/thy. 1998.8.15)
4. Bishop-Pitman M, Abele J, Ali SZ, Duick D, Elsheikh TM, Brooke Jeffrey R, Powers CN, Randolph G, Renshaw A & Scoutt L. Techniques for thyroid FNA: a synopsis of the National Cancer Institute thyroid fine-needle aspiration state of the science conference. Diagnostic Cytopathology 2008 36 407-424. (doi:10.1002/dc.20829)
5. Baloch ZW & LiVolsi VA. Follicular-patterned lesions of the thyroid: the bane of the pathologist. American Journal of Clinical Pathology 2002 117 143-150. (doi:10.1309/8VL9-ECXYNVMX-2RQF)
6. Baloch ZW, Fleisher S, LiVolsi VA & Gupta PK. Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology. Diagnostic Cytopathology 2002 26 41-44. (doi:10.1002/dc.10043)
7. Poller DN, Ibrahim AK, Cummings MH, Mikel JJ, Boote D & Perry M. Fine-needle aspiration of the thyroid. Importance of an indeterminate diagnostic category. Cancer Cytopathology 2000 90 239-244. (doi:10.1002/1097- 0142(20000825)90:4⟨239::AID-CNCR7⟩3.0.CO;2-S)
8. Greaves TS, Olvera M, Florentine BD, Raza AS, Cobb CJ, Tsao- Wei DD, Groshen S, Singer P, Lopresti J & Martin SE. Follicular lesions of thyroid. A 5-year fine-needle aspiration experience. Cancer Cytopathology 2000 90 335-341.
9. Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, Vielh P, DeMay RM, Sidawy MK & Frable WJ. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Fine-needle aspiration state-of-science conference. Diagnostic Cytopathology 2008 36 425-437. (doi:10.1002/dc.20830)
10. Griffith OL, Chiu CG, Gown AM, Jones SJM & Wiseman SM. Biomarker panel diagnosis of thyroid cancer: a critical review. Expert Review of Anticancer Therapy 2008 8 1399-1413. (doi:10.1586/14737140.8.9.1399)
11. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R & Larsson O. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 2001 357 1644-1650. (doi:10.1016/S0140-6736(00)04817-0)
12. Papotti M, Volante M, Saggiorato E, Deandreis D, Veltri A & Orlandi F. Role of galectin-3 immunodetection in the cytological diagnosis of thyroid cystic papillary carcinoma. European Journal of Endocrinology 2002 147 515-521. (doi:10.1530/eje.0.1470515)
13. Herrmann ME, LiVolsi VA, Pasha TL, Roberts SA, Wojcik EM & Baloch ZW. Immunohistochemical expression of galectin-3 in benign and malignant thyroid 5-year lesions. Archives of Pathology & Laboratory Medicine 2002 126 710-713. (Pubitemid 34602574)
14. Miettinen M & Kovatich AJ. HBME-1 monoclonal antibody useful in the differential diagnosis of mesothelioma, adenocarcinoma and soft tissue and bone tumors. Applied Immunohistochemistry and Molecular Morphology 1995 3 115-122.
15. Cheung CC, Ezzat S, Freeman JL, Rosen IB & Asa SL. Immunohistochemical diagnosis of papillary thyroid carcinoma. Modern Pathology 2001 14 338-342. (doi:10.1038/modpathol.3880312)
16. Rossi ED, Raffaelli M, Mule' A, Miraglia A, Lombardi CP, Vecchio FM & Fadda G. Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid. Histopathology 2006 48 795-800. (doi:10.1111/j.1365-2559.2006.02428.x)
17. Dabbs D, Abendroth CS, Grenko RT, Wang X & Gail ER. Immunocytochemistry on the ThinPrep processor. Diagnostic Cytopathology 1997 17 388-392. (doi:10.1002/(SICI)1097-0339(199711)17:5⟨388::AID- DC14⟩3.0.CO;2-J)
18. Tabbara SO, Sidaway MK, Frost AR, Brosky KR, Coles V, Hecht S, Radcliffe G & Sherman ME. The stability of estrogen and progesterone receptor expression on breast carcinoma cells stored as preservCyt suspension and as ThinPrep slides. Cancer Cytopathology 1998 84 355-360. (doi:10.1002/(SICI)1097- 0142(19981225)84:6⟨355::AID-CNCR7⟩3.0.CO;2-H)
19. Fadda G, Rossi ED, Mulè A, Miraglia A, Vecchio FM & Capelli A. Diagnostic efficacy of immunocytochemistry on fine needle aspiration biopsies processed by thin-layer cytology. Acta Cytologica 2006 50 129-135. (doi:10.1159/000325920)
20. Biscotti CV, Hollow JA, Toddy SM & Easley KA. ThinPrep versus conventional smears cytological preparations in the analysis of thyroid fine-needle aspiration 5-year specimens. American Journal of Clinical Pathology 1995 104 150-153.
21. Frost AR, Sidawy MK, Ferfelli M, Tabbara SO, Bronner NA, Brosky KR & Sherman ME. Utility of thin-layer preparations in thyroid fine-needle aspiration. Cancer Cytopathology 1998 84 17-25. (doi:10.1002/(SICI)1097- 0142(19980225)84:1⟨17::AID-CNCR4⟩3.0.CO;2-C)
22. Michael CW & Hunter B. Interpretation of fine-needle aspirates processed by ThinPrep technique: cytologic artifacts and diagnostic pitfalls. Diagnostic Cytopathology 2000 23 6-13. (doi:10.1002/1097-0339(200007)23: 1⟨6::AID-DC2⟩3.0.CO;2-F)
23. Scurry JP & Duggan MA. Thin layer compared to direct smear in thyroid fine-needle aspiration. Cytopathology 2000 11 104-115. (doi:10.1046/j.1365- 2303.2000.00228.x)
24. Afify AM, Liu J & Al-Khafaji BM. Cytologic artifacts and pitfalls of thyroid fine-needle aspiration using ThinPrep. Cancer Cytopathology 2001 93 179-186. (doi:10.1002/cncr.9027)
25. Cochand-Priollet B, Prat JJ, Polivka M, Thienpont L, Dahan H, Wassef M & Guillausseau PJ. Thyroid fine needle aspiration: the morphological features on ThinPrep slide preparations. Eighty cases with histological control. Cytopathology 2003 14 343-349. (doi:10.1046/j.0956-5507.2003.00098.x)
26. Fadda G, Rossi ED, Raffaelli M, Mulè A, Pontecorvi A, Miraglia A, Lombardi CP & Vecchio FM. Fine-needle aspiration biopsy of thyroid lesions processed by thin-layer cytology: one-year institutional experience with histologic correlation. Thyroid 2006 16 975-981. (doi:10.1089/thy.2006.16.975)
27. Rossi ED, Raffaelli M, Zannoni GF, Pontecorvi A, Mulè A, Callà C, Lombardi CP & Fadda G. Diagnostic efficacy of conventional as compared to liquid-based cytology in thyroid lesions. Evaluation of 10,360 fine needle aspiration cytology cases. Acta Cytologica 2009 53 659-666. (doi:10.1159/000325407)
28. British Thyroid Association Guidelines for the Management of Thyroid Cancer. 2nd edn, 2007.
29. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL & Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009 19 1-48. (doi:10.1089/thy.2009.0110)
30. Ravetto C, Colombo L & Dottorini ME. Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma. A retrospective study in 37,895 patients. Cancer Cytopathology 2000 90 357-363. (doi:10.1002/1097- 0142(20001225)90:6⟨357::AID-CNCR6⟩3.0.CO;2-4)
31. Nga ME, Kumarasinghe MP, Tie B, Sterrett GF, Wood B, Walsh J, Nguyen H, Whyte A & Frost FA. Experience with standardized thyroid fine-needle aspiration reporting categories. Cancer Cytopathology 2010 118 423-433 (published online). (doi:10.1002/cncy.20111)
32. Yang J, Schnadig V, Logrono R & Wassermann PG. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinic correlations. Cancer 2007 111 306-315. (doi:10.1002/cncr.22955)
33. Faquin WC & Baloch ZW. Fine-needle aspiration of follicular patterned lesions of the thyroid: diagnosis, management and follow-up according to NCI recommendations. Diagnostic Cytopathology 2010 38 731-739. (doi:10.1002/dc. 21292)
34. Rossi ED, Raffaelli M, Minimo C, Mule' A, Lombardi CP, Vecchio FM & Fadda G. Immunocytochemical evaluation of thyroid neoplasms on thin-layer smears from fine-needle aspiration biopsies. Cancer Cytopathology 2005 105 87-95. (doi:10.1002/cncr.21026)
35. Sack MJ, Astengo-Osuna C, Lin BT, Battifora H & LiVolsi VA. HBME-1 immunostaining in 5-year thyroid fine-needle aspirations: a useful marker in the diagnosis of carcinoma. Modern Pathology 1997 10 668-674.
36. Beesley MF & McLaren KM. Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules. Histopathology 2002 41 236-243. (doi:10.1046/j.1365-2559.2002.01442.x)
37. Saggiorato E, De Pompa R, Volante M, Cappia S, Arecco F, Dei Tos AP, Orlandi F & Papotti M. Characterization of thyroid "follicular neoplasms" in fine-needle aspiration cytologic specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocrine-Related Cancer 2005 12 305-317. (doi:10.1677/erc.1.00944)
38. Schmitt FC, Longatto-Filho A, Valent A & Vielh P. Molecular techniques in cytopathology practice. Journal of Clinical Pathology 2008 61 258-267. (doi:10.1136/jcp.2006.044347)
39. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K & Nikiforova MN. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. Journal of Clinical Endocrinology and Metabolism 2009 94 2092-2098. (doi:10.1210/jc.2009-0247)
40. Ohori NP, Nikiforova MN, Schoedel KE, LeBeau SO, Hodak SP, Seethala RR, Carty SE, Ogilvie JB, Yip L & Nikiforov YE. Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance". Cancer Cytopathology 2010 118 17-23. (doi:10.1002/cncy.20063)